Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

624
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
624
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preference-based scoring algorithm to estimate societal utilities based on the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) instrument.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Impurity Profiling of an Antibody-Antibiotic Conjugate (AAC) Drug-Linker Using Multiple 2D-LC Modes.

Journal of separation science·2026
Same author

Understanding Blood-Injection-Injury Phobia: Do Not Miss the Point.

A&A practice·2026
Same author

Insights into siRNA Duplex Stability by UV Spectrophotometry Absorbance and Melting Temperature Analyses.

ACS omega·2026
Same author

The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement.

Structure (London, England : 1993)·2025
Same author

Real-Time Bioconjugation Reaction Monitoring of Antibody-Drug Conjugates with Multiattribute High-Throughput Hydrophobic Interaction Chromatography.

Analytical chemistry·2025

Related Experiment Video

Updated: Jan 19, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K

Network-based method for drug target discovery at the isoform level.

Jun Ma1,2, Jenny Wang2, Laleh Soltan Ghoraie2

  • 1National Engineering Research Center for Miniaturized Detection Systems, College of Life Sciences, Northwest University, Xi'an, P.R. China.

Scientific Reports
|September 27, 2019
PubMed
Summary

This study introduces a novel method to identify specific protein isoforms as drug targets. This approach enhances drug development by focusing on the most relevant molecular variants for targeted therapies.

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K

Related Experiment Videos

Last Updated: Jan 19, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.5K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.4K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Computational Biology

Background:

  • Identifying specific protein targets is crucial for drug development and understanding molecular mechanisms.
  • Most genes produce multiple protein isoforms with distinct functions, complicating target identification.
  • Current methods often overlook the importance of specific isoforms in drug response.

Purpose of the Study:

  • To develop and validate a computational method for identifying major drug target isoforms.
  • To analyze the characteristics of identified target isoforms using diverse biological datasets.
  • To predict and test specific isoform targets for key genes in cancer.

Main Methods:

  • Integrated cancer-specific isoform coexpression networks with gene perturbation signatures.
  • Utilized the 'shortest path' drug target prioritization method within the Connectivity Map database.
  • Validated the algorithm using leukemia cancer network and differential expression data.
  • Analyzed isoform properties using pharmacogenomic, proteomic, and public isoform annotation datasets (APPRIS, STRING).

Main Results:

  • Successfully identified major target isoforms for genes including DNMT1, MGEA5, and P4HB4.
  • Identified isoforms were not always annotated as principal isoforms in standard databases.
  • In silico docking confirmed the binding affinity of a specific MGEA5 isoform to streptozocin.

Conclusions:

  • The developed method effectively identifies functionally relevant drug target isoforms.
  • This isoform-level analysis offers a more precise approach to drug discovery and development.
  • Findings pave the way for developing more effective and targeted therapies by considering protein isoforms.